Last Updated: 09/10/07
Michaele Christian, M.D.
Former Associate Director
Cancer Therapy Evaluation Program
Michaele Chamblee Christian, M.D., was appointed Associate Director of the Cancer Therapy Evaluation Program of DCTD in 1997. She previously worked in the Investigational Drug Branch overseeing the clinical development of novel anticancer drugs. In 1995, she established NCI’s Clinical Trials Monitoring Branch, which oversees quality assurance and compliance for hundreds of NCI clinical trials.
Dr. Christian received her M.D. from Georgetown University School of Medicine, graduating summa cum laude. Additionally, she completed residency training in internal medicine and fellowships in hematology and oncology at Georgetown. Among numerous awards, Dr. Christian received the Kober Award for highest academic achievement and was elected to Alpha Omega Alpha medical honor society. Her research interests include early therapeutics development, ovarian cancer treatment, clinical trial design, and enhancing participation of under-represented populations in clinical trials.
Dr. Christian is often asked to speak about new opportunities in clinical research, including accelerating bench to bedside or practical translational research, using clinical trials networks to address broader transdisciplinary research questions, and the growing use of international collaborations to conduct research that addresses global medical needs.
